The Ensign Group, Inc. (ENSG) Stock Analysis 2026

HealthcareMedical Care Facilities

BriMind AI Score

Proprietary
57
Moderate
Price CAGR
25.6%
1Y Return
-5.6%
Analyst Upside
+25.3%
Rev Growth
17.3%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

ENSG Revenue & Profitability Breakdown

This chart shows how ENSG's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$5.49B
Cost of Revenue
-$4.58B
Gross Profit
$908.9M16.6% margin
Operating Expenses
-$413.2M
Operating Income
$495.7M9.0% margin
Tax & Other
-$117.0M
Net Income
$378.7M6.9% margin
Gross Margin
16.6%
Operating Margin
9.0%
Net Margin
6.9%

Key Financial Metrics

The Ensign Group, Inc. trades at a trailing P/E of 26.87x, generates $280.6M in free cash flow, runs a debt/equity ratio of 92.03, and converts shareholder equity into profit at a 17.0% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$10.04B
P/E (Trailing)
26.87
P/E (Forward)
20.14
PEG Ratio
1.49
Price / Book
4.08
Revenue
$5.49B
Revenue Growth
17.3%
Earnings Growth
16.7%
EPS (Trailing)
$6.41
EPS (Forward)
$8.55
Gross Margin
16.6%
Operating Margin
9.0%
Net Margin
6.9%
Return on Equity
17.0%
Return on Assets
5.5%
Free Cash Flow
$280.6M
Debt / Equity
92.03
Current Ratio
1.21
Quick Ratio
1.12
Beta
0.69
Dividend Yield
0.1%
Payout Ratio
4.0%
Insider Ownership
3.5%
Inst. Ownership
92.7%
Short % Float
3.1%
Book Value / Share
$42.26

Wall Street Analyst Consensus

Wall Street analysts covering The Ensign Group, Inc. currently haven't converged on a clear consensus rating, with a mean 12-month price target of $220.00. Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Mean Target$220.00

Intrinsic Value Estimates for ENSG

We use 3 valuation models to estimate ENSG's intrinsic value. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

Graham Number
$78.07
Benjamin Graham's formula: √(22.5 × EPS × Book Value). A conservative floor value for stable, profitable companies. Works best for value-oriented businesses.
P/E Based (15× trailing)
$96.15
Multiplies trailing 12-month earnings per share by 15× — a historically average P/E for the stock market. Simple but ignores future growth.
P/E Based (15× forward)
$128.29
Multiplies next year's estimated earnings per share by 15×. More forward-looking; useful for high-growth companies where current earnings understate potential.
Fair Value Range
$78.07 – $128.29
Average Estimate
$100.84

Intrinsic value estimates use simplified models (Graham, DCF, P/E) and conservative assumptions. They should be used as one input among many — not as sole buy/sell guidance. For advanced analysis, see the full platform.

Technical Price Signals

ENSG is currently in a mixed technical position. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

50-Day MA
$173.81
200-Day MA
$182.43

Further Reading

Research and guides that put ENSG’s numbers in context — how to read the filings behind them, and the frameworks we use to score them.

Market Theory10-Year Treasury Yield Hits 19-Year High: What 5.2% Means for StocksRisk ManagementBest ETFs for a Recession-Proof Portfolio in 2026FundamentalsHow to Read a 10-K Annual Report: Complete Investor GuideFundamentals10 Stock Analysis Tools Every Investor Should Know About

More Healthcare Stock Analysis

In-depth reports on companies operating alongside ENSG — business models, bull and bear cases, and the metrics that matter.

HCAHCA Healthcare, Inc.Medical Care FacilitiesRXRXRecursion Pharmaceuticals, Inc.BiotechnologyUNHUnitedHealth Group IncorporatedHealthcare PlansREGNRegeneron Pharmaceuticals, Inc.BiotechnologySRPTSarepta Therapeutics, Inc.BiotechnologyDXCMDexCom, Inc.Medical DevicesCAHCardinal Health, Inc.Medical DistributionPRGOPerrigo Company plcDrug Manufacturers - Specialty & Generic

Unlock the Full ENSG Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis